Bz-Phe-Val-Arg-AMC is a fluorogenic substrate for characterizing trypsin-like protease activity. Its AMC group enables sensitive detection of enzymatic hydrolysis. Researchers utilize it to measure kinetics and analyze sequence-driven cleavage determinants. The peptide supports high-resolution enzymology and inhibitor screening efforts.
CAT No: T05067
CAS No:88899-22-3
Synonyms/Alias:BZ-PHE-VAL-ARG-AMC;Bz-FVR-AMC;88899-22-3;N-[(2S)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]benzamide;N-Benzoyl-Phe-Val-Arg 7-amido-4-methylcoumarin;HY-D1634;FB110481;CS-0608587;N-((S)-1-((S)-1-((S)-5-guanidino-1-(4-methyl-2-oxo-2H-chromen-7-ylamino)-1-oxopentan-2-ylamino)-3-methyl-1-oxobutan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)benzamide;
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More